CrestPoint Capital Management’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$450K Sell
7,100
-8,400
-54% -$598K 0.25% 128
2017
Q3
$1.21M Sell
15,500
-2,600
-14% -$198K 0.54% 63
2017
Q2
$1.42M Buy
18,100
+5,000
+38% +$349K 0.66% 50
2017
Q1
$756K Buy
13,100
+3,400
+35% +$184K 0.36% 102
2016
Q4
$482K Buy
9,700
+500
+5% +$26K 0.24% 138
2016
Q3
$513K Buy
+9,200
New +$487K 0.26% 127

Other funds holding MDSO

CrestPoint Capital Management's MDSO Position: Q4 2017 in Review

CrestPoint Capital Management reduced its Medidata Solutions, Inc. (MDSO) stake by 54% in Q4 2017, selling an estimated $598K and leaving 7,100 shares worth $450K. The position accounts for 0.25% of the portfolio, ranked #128.

CrestPoint Capital Management first reported a position in MDSO in Q3 2016 and has held it in 6 quarters since. The position peaked at $1.42M in Q2 2017. 285 funds tracked by Wall St. Rank hold MDSO as of Q4 2017.

  • CrestPoint Capital Management held 7,100 shares of Medidata Solutions, Inc. worth $450K as of Q4 2017.
  • CrestPoint Capital Management sold 8,400 Medidata Solutions, Inc. shares in Q4 2017, an estimated $598K.
  • Medidata Solutions, Inc. made up 0.25% of CrestPoint Capital Management's portfolio in Q4 2017, its #128 holding.
  • CrestPoint Capital Management first reported a position in Medidata Solutions, Inc. in Q3 2016 and has held it in 6 quarters since.
  • CrestPoint Capital Management's Medidata Solutions, Inc. position peaked at $1.42M in Q2 2017.
  • 285 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.